Sakar Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE732S01012
  • NSEID: SAKAR
  • BSEID:
INR
484.00
-12.55 (-2.53%)
BSENSE

Feb 10

BSE+NSE Vol: 97445

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
70.34
57.56
52.74
50.24
43.42
42.78
41.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
70.34
57.56
52.74
50.24
43.42
42.78
41.15
Raw Material Cost
38.54
29.61
28.76
26.03
24.93
22.01
22.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-3.01
0.80
0.20
-11.36
-2.29
0.88
-0.44
Employee Cost
9.89
8.34
7.55
15.89
4.92
5.46
5.38
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
-0.01
0.00
-0.01
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
6.32
7.46
3.53
3.95
4.11
2.92
3.01
Total Expenditure (Excl Depreciation)
51.75
46.21
40.03
34.51
31.66
31.28
30.45
Operating Profit (PBDIT) excl Other Income
18.59
11.35
12.71
15.73
11.76
11.50
10.70
Other Income
0.51
1.21
0.39
0.18
0.30
0.37
0.46
Operating Profit (PBDIT)
19.10
12.56
13.10
15.91
12.06
11.87
11.16
Interest
1.78
1.53
2.14
4.19
1.30
1.64
1.40
Exceptional Items
0.00
0.00
0.00
0.00
-0.05
0.00
0.00
Gross Profit (PBDT)
17.32
11.03
10.96
11.72
10.71
10.23
9.76
Depreciation
6.37
5.68
5.57
5.48
5.23
5.12
5.06
Profit Before Tax
10.95
5.36
5.38
6.24
5.48
5.11
4.70
Tax
0.70
0.82
0.71
0.48
0.94
0.31
2.29
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.25
4.54
4.67
5.76
4.53
4.80
2.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10.25
4.54
4.67
5.76
4.53
4.80
2.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.25
4.54
4.67
5.76
4.53
4.80
2.41
Equity Capital
22.25
22.25
22.25
21.95
21.95
21.75
21.75
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.61
2.04
2.1
2.62
2.06
2.21
1.11
Diluted Earnings per share
4.59
2.03
2.11
2.65
2.08
2.16
1.09
Operating Profit Margin (Excl OI)
26.43%
19.72%
24.1%
31.31%
27.08%
26.88%
26.0%
Gross Profit Margin
24.62%
19.16%
20.78%
23.33%
24.67%
23.91%
23.72%
PAT Margin
14.57%
7.89%
8.85%
11.46%
10.43%
11.22%
5.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 62.00% vs 16.63% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 126.27% vs 118.84% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 58.08% vs 30.52% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 36.92% vs -27.37% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Sakar Healthcare With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
70.34
180.26
-109.92
-60.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
70.34
180.26
-109.92
-60.98%
Raw Material Cost
38.54
93.86
-55.32
-58.94%
Purchase of Finished goods
0.00
1.90
-1.90
-100.00%
(Increase) / Decrease In Stocks
-3.01
-9.51
6.50
68.35%
Employee Cost
9.89
20.83
-10.94
-52.52%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
35.66
-35.66
-100.00%
Other Expenses
6.32
0.00
6.32
Total Expenditure (Excl Depreciation)
51.75
142.74
-90.99
-63.75%
Operating Profit (PBDIT) excl Other Income
18.59
37.52
-18.93
-50.45%
Other Income
0.51
2.52
-2.01
-79.76%
Operating Profit (PBDIT)
19.10
40.04
-20.94
-52.30%
Interest
1.78
0.01
1.77
17,700.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
17.32
40.03
-22.71
-56.73%
Depreciation
6.37
6.56
-0.19
-2.90%
Profit Before Tax
10.95
33.47
-22.52
-67.28%
Tax
0.70
7.89
-7.19
-91.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10.25
25.58
-15.33
-59.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10.25
25.58
-15.33
-59.93%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.25
25.58
-15.33
-59.93%
Equity Capital
22.25
13.37
8.88
66.42%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.61
19.13
-14.52
-75.90%
Diluted Earnings per share
4.59
19.14
-14.55
-76.02%
Operating Profit Margin (Excl OI)
26.43%
20.81%
0.00
5.62%
Gross Profit Margin
24.62%
22.21%
0.00
2.41%
PAT Margin
14.57%
14.19%
0.00
0.38%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 70.34 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 22.20% vs 9.14% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 62.00% vs 16.63% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.25 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 125.77% vs -2.78% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 126.27% vs 118.84% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.59 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 63.79% vs -10.70% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 58.08% vs 30.52% in Dec 2024

Quarterly - Interest
Interest 1.78 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 16.34% vs -28.50% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 36.92% vs -27.37% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.43%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024